BridgeMD
New treatment option for Sarcopenia
Official title Effects of Polyphenol Supplementation and Exercise on Physical Performance in Older Adults
ClinicalTrials.gov ID: NCT07441343
What this study is testing
- What it's testing
- After approximately age 40 years, individuals experience a natural loss of muscle mass, strength, and physical function that is linked to higher risks of falls, disability, loss of independence, and mortality. These losses can also be a precursor to the development of frailty, which includes factors beyond impaired physical function such as cognitive impairment, psychological disorder, increased likelihood of hospitalization, need of long term-care, and mortality.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 60 and older. Healthy volunteers may be eligible.
You may be able to join if
- Female or Male
- Age \> 60y
- Non-Smoking
- English Speaking
You likely can't join if
- Self-reported highly trained individual (training \>3x/week for a specific sport with the goal to compete at a high level)
- BMI \< 18.5
- Uses insulin to control blood glucose levels
- Any medical, orthopaedic, or psychiatric condition that would be comprise ability to comply with study requirements
- Regular user of anti-inflammatory and/or analgesic medication
- History of neuromuscular disorder or muscle/bone wasting disease
See the full eligibility criteria
- Female or Male
- Age \> 60y
- Non-Smoking
- English Speaking
- Self-reported highly trained individual (training \>3x/week for a specific sport with the goal to compete at a high level)
- BMI \< 18.5
- Uses insulin to control blood glucose levels
- Any medical, orthopaedic, or psychiatric condition that would be comprise ability to comply with study requirements
- Regular user of anti-inflammatory and/or analgesic medication
- History of neuromuscular disorder or muscle/bone wasting disease
- Determined not ready for exercise by the CSEP GAQ
- Use of medication known to affect protein metabolism
- Family history of thrombosis, platelet or coagulation disorders, or antiplatelet therapy
- Use of anticoagulant medication
- Personal or family history of clotting disorder or deep vein thrombosis
The study team makes the final eligibility decision.
Where it's taking place
- Kingston, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 60 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kingston, Ontario, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.